Chiral phosphine ligands

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.4020-99-9,Methoxydiphenylphosphine,as a common compound, the synthetic route is as follows.

In a 1000 ml reaction flask was charged with 99.5 g (0.46 mol)Diphenylmethoxyphosphine (purity ? 99.5%) and 109.7 g(0.64 mol) of m-methoxybenzyl chloride (content of ? 99.2%), heated to 58 C with stirring, and incubated at this temperature for 8 hours, The end of Paul to cool to 15 C, directly into the next step reaction., 4020-99-9

As the paragraph descriping shows that 4020-99-9 is playing an increasingly important role.

Reference£º
Patent; Suzhou Chengche Pharmaceutical & Chemical Co., Ltd; Xia, Qiujing; (6 pag.)CN105541565; (2016); A;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

18437-78-0, Tris(4-fluorophenyl)phosphine is a chiral-phosphine-ligands compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Under inert gas protection conditions,To a flask equipped with a stirring magnet, 344 mg of Fe2S2(CO)6 (1 mmol) and 30 mL of tetrahydrofuran solvent were added.A dark red solution was obtained, and the resulting solution was cooled to -78 ¡ã C with a liquid nitrogen bath.2.1 mL of lithium triethylborohydride (1M in THF) solution was slowly added under stirring.After reacting for 15 min, 0.2 mL of trifluoroacetic acid (2.5 mmol) was added and the reaction was continued for 15 min.Add 348 mg of P(C6H4-4-F)3 (1.1 mmol), stir at room temperature for 3 h before adding788 mg of I-4-C6H4N(CH2Cl)2 (2.5 mmol) and 0.3 mL of triethylamine were stirred at room temperature for 12 h.The solvent of tetrahydrofuran was removed by rotary distillation, and the residue was extracted with dichloromethane, and then subjected to thin-layer chromatography using a solvent of dichloromethane/petroleum ether ratio of 1:5 to collect a main color band to obtain a model 2 .

18437-78-0, 18437-78-0 Tris(4-fluorophenyl)phosphine 140387, achiral-phosphine-ligands compound, is more and more widely used in various fields.

Reference£º
Patent; Sichuan University of Science and Engineering; Li Yulong; He Jiao; Wu Yu; Xie Ying; Jiang Jin; Sun Yanchun; Wang Zheng; Zou Like; Xie Bin; Gao Fan; Mu Chao; (11 pag.)CN109232665; (2019); A;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1070663-78-3,Dicyclohexyl(2′,4′,6′-triisopropyl-3,6-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine,as a common compound, the synthetic route is as follows.

1070663-78-3, [Pd(allyl)(brettphos)]OTf was synthesized according to the literature.[4] A dry Schlenk flask equipped with a Teflon-coated magnetic stirring bar was charged with [(allyl)PdCl]2 (183 mg, 0.5 mmol) followed by AgOTf (257 mg, 1.0 mmol). The flask was fitted with a rubber septum, evacuated, and backfilled with nitrogen. This evacuation/nitrogen backfill cycle was repeated two additional times. Solvent (10 mLof THF) was added, and the reaction mixture was stirred at room temperature for 30min while protected from light. A second dry Schlenk flask was equipped with a magnetic stirring bar, fitted with a Schlenk frit, and charged with BrettPhos (537 mg,1.0 mmol). The flask was fitted with a rubber septum, and it was evacuated andbackfilled with nitrogen. This evacuation/nitrogen backfill cycle was repeated twoadditional times. The solution from the first Schlenk flask was transferred through amillipore filter (to remove AgCl) into the second Schlenk flask containing the ligand,rinsing with 5 mL of additional solvent (THF). This mixture was stirred at roomtemperature for 2 h. Hexanes (450 mL) was then added to the mixture to fullyprecipitate the product. The solid materials were then collected by suction filtration,washed with additional hexanes, and dried in vacuo to give 734 mg (86%) of the titlecompound as a yellow solid.

1070663-78-3 Dicyclohexyl(2′,4′,6′-triisopropyl-3,6-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine 25112535, achiral-phosphine-ligands compound, is more and more widely used in various fields.

Reference£º
Article; Liu, Wentong; Kuang, Yi; Wang, Zhifan; Zhu, Jin; Wang, Yuanhua; Beilstein Journal of Organic Chemistry; vol. 15; (2019); p. 542 – 550;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.855-38-9,Tris(4-methoxyphenyl)phosphine,as a common compound, the synthetic route is as follows.,855-38-9

EXAMPLE 8 N-(4-Fluorophenyl)-6-[1-methyl-3-(trifluoromethyl)pyrazol-5-yloxy]pyridine-2-carboxamide The procedure was as described in Example 4. 4.92 g of crude product was obtained in the form of a light yellow solid from 3.47 g (12.5 mmol) of 2-chloro-6-[1-methyl-3-(trifluoromethyl)pyrazol-5-yloxy]pyridine, 2.08 g (18.7 mmol) of 4-fluoroaniline, 1.46 g (13.8 mmol) of sodium carbonate, 5.6 mg (25 mumol) of palladium(II) acetate and 0.13 g (375 mumol) of tris(4-methoxyphenyl)phosphine in 12.5 ml of xylene after 21 hours at 150 C. under a CO pressure of 19 bar (GC: complete conversion). It was purified by recrystallization from methylcyclohexane. The yield was 3.97 g (84.4 percent) of light beige crystals. Other data concerning the product was: M.p.: 138-139 C. 1 H NMR (CDCl3): delta=3.85 (s, 3H); 6.41 (s, 1H); 7.06 (m, 2H); 7.29 (d, J=8.1 Hz, 1H); 7.59 (m, 2H); 8.05 (t, J=8.1 Hz, 1H); 8.14 (d, J=8.1 Hz, 1H); 9.28 (bs,1H).

855-38-9 Tris(4-methoxyphenyl)phosphine 70071, achiral-phosphine-ligands compound, is more and more widely used in various fields.

Reference£º
Patent; Lonza AG; US5892032; (1999); A;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.13440-07-8,Di(naphthalen-1-yl)phosphine oxide,as a common compound, the synthetic route is as follows.

Add in the reaction bottle4-phenylbutyne (0.065 g, 0.5 mmol), dinaphthyl phosphorus (0.30 g, 1 mmol),Cu(SCN)2 (0.0179 g, 0.1 mmol), tert-butyl peroxide (0.30 mL, 2 mmol) and water (2 mL),60oC reaction;TLC tracks the reaction until it is completely over;The crude product obtained after the completion of the reaction was separated by column chromatography (ethyl acetate: petroleum ether = 1:1) to give the desired product.(Yield 85%)., 13440-07-8

As the paragraph descriping shows that 13440-07-8 is playing an increasingly important role.

Reference£º
Patent; Nantong Textile Silk Industrial Technology Institute; Soochow University (Suzhou); Zou Jianping; Tao Zekun; Lv Shuaishuai; Li Chengkun; Li Jianan; (12 pag.)CN109096336; (2018); A;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

4559-70-0,With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.4559-70-0,Diphenylphosphine oxide,as a common compound, the synthetic route is as follows.

General procedure: Under an argon atmosphere, the carbonyl compounds (0.24 mmol, 1.2 eq), TsNHNH2 (0.252 mmol, 1.26 eq) and anhydrous dioxane (2.0 mL) were successively added to a flame-dried Schlenk flask. The reaction was heated at 60 ?C with stirring for 30 minutes. After the solution cooled down to room temperature diphenyl phosphine oxide 1a (0.20 mmol, 1.0 eq), K2CO3 (0.60 mmol, 3.0 eq), and CuI (0.02 mmol, 10 mol %) were sequentially added to the system. The mixture was stirred to reflux. When the reaction was considered complete, as determined by TLC analysis, the reaction mixture was cooled to room temperature. Water was added to the mixture and extracted with ethyl acetate twice. The combined organic phase was washed with brine and dried over Na2SO4. The concentrated residue was purified by column chromatography over silica gel using petroleum ether/ethyl acetate (1:1) as eluent to get the product.

The synthetic route of 4559-70-0 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Chen, Zi-Sheng; Zhou, Zhao-Zhao; Hua, Hui-Liang; Duan, Xin-Hua; Luo, Jian-Yi; Wang, Jia; Zhou, Ping-Xin; Liang, Yong-Min; Tetrahedron; vol. 69; 3; (2013); p. 1065 – 1068;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

17261-28-8, 2-(Diphenylphosphino)benzoic acid is a chiral-phosphine-ligands compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

17261-28-8, 2-(Diphenylphosphanyl)benzoic acid (0.50 g, 1.63 mmol) and DMAP (20 mg, 0.163 mmol) were dissolved in CH2Cl2 (10 mL). Ethanethiol (EtSH, 0.35 mL, 4.89 mmol) was added, and the solution was placed under Ar(g) and cooled to 0¡ã C. DIC (0.25 mL, 1.63 mmol) was added dropwise, and the resulting solution was allowed to warm to room temperature and stirred overnight. The solution was then filtered, and the filtrate was concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography, eluting with 10percent EtOAc/hexanes, to give phosphine 1b as a pale yellow solid (0.43 g, 1.22 mmol, 75percent yield).Data for 1b: 1H NMR (400 MHz, CDCl3) delta=8.02 (m, 1H, Ar.), 7.45-7.24 (m, 12H, Ar.), 6.99 (m, 1H, Ar.), 2.98 (q, 2H, J=7.4 Hz, SCH2CH3), 1.22 (t, 3H, J=7.4 Hz, SCH2CH3). 13C NMR (100 MHz, CDCl3, 31P-coupled; 1H-decoupled, observed signals) delta=192.7, 141.9, 141.7, 138.0, 137.8, 137.7, 134.6, 134.0, 133.8, 131.7, 128.9, 128.6, 128.4, 128.4, 128.3, 24.0, 14.6. 31P NMR (162 MHz, CDCl3) delta=-5.8. HRMS (ESI+) m/z calculated for (C21H20OPS)+ 351.0968, measured 351.0953.

The synthetic route of 17261-28-8 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; Raines, Ronald Thaddeus; Myers, Eddie Leonard; US2010/125132; (2010); A1;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.166330-10-5,(Oxybis(2,1-phenylene))bis(diphenylphosphine),as a common compound, the synthetic route is as follows.

General procedure: Cu(I) complexes were synthesized by the following route: [Cu(CH3CN)4](PF6) (0.124g, 0.4mmol) and bis(2-(diphenylphosphanyl)phenyl ether (POP) (0.216g, 0.4mmol) reacted in dichloromethane (15mL) at 25C for 2h. Then, the corresponding ligand (0.4mmol) was dissolved in the degassed dichloromethane solution and injected into the mixed solution for 2h. The resulting mixture was filtered through a plug of Celite and concentrated to ca. 1mL. Addition of Et2O (10mL) to the filtrate afforded a pale yellow precipitate, which was collected and washed with Et2O. And the product was recrystallized with ethanol., 166330-10-5

166330-10-5 (Oxybis(2,1-phenylene))bis(diphenylphosphine) 4285986, achiral-phosphine-ligands compound, is more and more widely used in various fields.

Reference£º
Article; Chai, Chaoyang; Xu, Shengxian; Wang, Jinglan; Zhao, Feng; Xia, Hongying; Wang, Yibo; Inorganica Chimica Acta; vol. 488; (2019); p. 34 – 40;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1608-26-0,N,N,N’,N’,N”,N”-Hexamethylphosphinetriamine,as a common compound, the synthetic route is as follows.

Example 4; (g) Preparation of tri(dimethylamino) butylphosphonium butylsulfate; In an eggplant-shaped two-neck flask equipped with a reflux condenser, a dropping funnel and a magnetic stirrer, 37.4 g (178 mmol) of diethylsulfate were added dropwise to 24.2 g (149 mmol) of hexamethylphosphorous triamide at room temperature in a nitrogen gas atmosphere. After 3-day stirring at room temperature, a white solid salt was obtained. The salt was washed sufficiently with ether and vacuum-dried at 50C for 5 hours to obtain tri(dimethylamino) butylphosphonium butylsulfate with 94% yield. The resulting compound was identified with a nuclear magnetic resonance spectrometer (BRUKER Ultra Shield 300 NMR Spectrometer, supplied by BRUKER Corp.). The spectrum data are shown below. 1H-NMR (300 MHz, solvent: acetone-d6, reference material: tetramethylsilane) delta 3.83 (t, 2H) 2.85 (d, 18H) 2.73-2.63 (m, 2H) 1.70-1.33 (m, 8H) 0.97 (t, 3H) 0.90 (t, 3H) The structural formula is shown below (a dashed line in the formula represents a conjugated structure)., 1608-26-0

The synthetic route of 1608-26-0 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; Kanto Denka Kogyo CO., LTD.; EP1876181; (2008); A1;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.564483-19-8,Di-tert-butyl(2′,4′,6′-triisopropyl-[1,1′-biphenyl]-2-yl)phosphine,as a common compound, the synthetic route is as follows.

Step 7: 1-(3-Fluoro-4-(1-(4-methoxybenzyl)-1H-1,2,4-triazol-3-yl)phenyl)-7,8,9,10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]inden-4-ol A mixture of 4-bromo-1-(3-fluoro-4-(1-(4-methoxybenzyl)-1H-1,2,4-triazol-3-yl)phenyl)-7,8,9,10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]indene (3.00 g, 5.47 mmol), di-tert-butyl(2′,4′,6′-triisopropyl-[1,1′-biphenyl]-2-yl)phosphine (1.16 g, 2.73 mmol), tris(dibenzylideneacetone)dipalladium(0) (2.50 g, 2.73 mmol) and potassium hydroxide (770 mg, 13.7 mmol) in dioxane (90 mL) and water (18 mL) was stirred at 100 C. for 4 h. The resulting mixture was evaporated in vacuo. The residue was purified via flash chromatography on silica gel (solvent gradient: 0-10% methanol in DCM) to yield 1.20 g (45%) of the title compound as a gray solid. LCMS: [M+H]+=486., 564483-19-8

The synthetic route of 564483-19-8 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; Genentech, Inc.; Braun, Marie-Gabrielle; Garland, Keira; Hanan, Emily; Purkey, Hans; Staben, Steven T.; Heald, Robert Andrew; Knight, Jamie; Macleod, Calum; Lu, Aijun; Wu, Guosheng; Yeap, Siew Kuen; (183 pag.)US2018/65983; (2018); A1;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate